Which platform is safer for patients with medical complexity
Our KaChava review has our full thoughts
It is approved by the Food and Drug Administration (FDA) for weight loss and long-term weight management in adults and adolescents 12 years and older with obesity, as well as adults who are overweight and have at least one weight-related health condition, such as high cholesterol or Type 2 diabetes
At worst, they could be doing damage that we wont know about for years to come
For melanocortin receptor pharmacology and MC4R pathway research, Melanotan-2 provides a valuable nonselective tool
And today we are talking about lifestyle medicine, weight loss, and medication as part of both of those components, and particularly the GLP-1 receptor agonist medications